16 October 2017 in Journal of Internal Medicine
20 August 2025 in JHEP Reports
Current guidelines recommend intravenous (i.v.) albumin for different indications in decompensated cirrhosis, but iatrogenic hypervolemia following i.v. albumin is increasingly reported. We aimed to characterize intravascular volume status using point-of-care ultrasound (POCUS) of the inferior vena cava (IVC) during passive leg raise (PLR) and i.v. albumin, potentially facilitating clinical management and adjustment of albumin dosage. This prospective pilot cohort included patients with decompensated cirrhosis requiring i.v. albumin. We assessed changes in minimal and maximal IVC diameters (IVCmin and IVCmax, respectively) and collapsibility index (IVCCI) during PLR and after i.v. albumin. We defined severe intravascular volume overload as IVCmax >2.1 cm and IVCCI <20%. Clinical outcomes were recorded until 3 months after POCUS. We included 81 measurements in 55 patients (70.9% men; median age 62 years; 58.2% alcohol-related cirrhosis; median Child-Pugh score 9 points; 89.1% paracentesis; median 40 g i.v. albumin; 5.5 L ascites). We found a significant increase in IVC diameters both during PLR (change in mean [Δ] IVCmin +20.7%, Δ IVCmax +14.1%, p <0.01) and after i.v. albumin (Δ IVCmin +58.8%, Δ IVCmax +48.2%, p <0.01). There was a significant decrease in IVCCI during PLR (relative Δ -11.1%, p <0.01) and after i.v. albumin (relative Δ -18.0%, p <0.01). Potential severe intravascular volume overload occurred on 17 occasions (21%) after i.v. albumin, more frequently in women than in men (40% vs. 15.7%, p <0.01), and showed higher cumulative incidence rates in variceal bleeding after 1 (16.7% vs. 0%, p = 0.01) and 3 months (18.2% vs. 0%, p = 0.01). Potential severe intravascular volume overload after i.v. albumin was detected in every fifth patient with decompensated cirrhosis. Thus, there is a need to develop strategies for individualizing volume management in patients with decompensated cirrhosis. Iatrogenic volume overload after albumin infusions in patients with cirrhosis is a potentially harmful side effect, but no policy for monitoring intravascular volume overload using non-invasive tools has been suggested so far. New-onset potential volume overload was detected in almost one out of five men and four out of 10 women and was associated with increases in N-terminal prohormone of brain natriuretic peptide, lower mean arterial pressure during albumin infusion, and higher serum sodium levels. Our results from this proof-of-concept study emphasize the need for larger prospective cohort studies to validate our findings and introduce strategies for individualizing volume management in patients with decompensated cirrhosis.
13 December 2025 in JHEP Reports
Patients with decompensated cirrhosis are susceptible to iatrogenic hypervolemia. A pilot study using point-of-care ultrasound (POCUS) of the inferior vena cava (IVC) found severe hypervolemia in 20% of patients after intravenous (IV) albumin, despite adherence to current guidelines. CPMX2 is a novel non-invasive device that uses external jugular vein (EJV) compression to assess central venous pressure, but its ability to predict post-albumin hypervolemia has not been studied. We aimed to track changes in intravascular volume status during passive leg raise (PLR) and IV albumin using both methods. IVC diameters (IVCmin, IVCmax) and IVC collapsibility index (IVCCI) were measured by POCUS, and EJV compression pressures (EJVmin, EJVmax, EJVmean) were measured by CPMX2, in parallel before and during PLR, as well as before and after IV albumin. Potential intravascular overload was defined as IVCmax >2.1 cm and IVCCI <50%, or EJVmean ≥9 mmHg. In this prospective cohort of 20 patients (35% women; median age 62 years; mean BMI 25.7 kg/m2; 55% Child-Pugh B; 80% receiving paracentesis), all IVC diameters and EJV compression pressures increased during PLR and after IV albumin. Percentage changes in EJV compression pressures were greater than changes in IVC diameters during PLR (mean EJVmax +88%, EJVmean +65% vs. IVCmax +16%, IVCmin +26%; all p <0.01). After IV albumin, changes were comparable between the methods (mean EJVmax +68%, EJVmin +80%, EJVmean +75% vs IVCmax +58%, IVCmin +79%). Potential post-albumin volume overload occurred in most cases (POCUS 65%, CPMX2 95%). Both POCUS and CPMX2 detected substantial volume changes during PLR and following IV albumin. CPMX2 appeared more sensitive to dynamic changes during PLR and identified more patients with potential post-albumin volume overload, suggesting it may help individualize fluid management in decompensated cirrhosis. Intravascular volume overload after albumin infusion is a major concern in patients with decompensated cirrhosis and was observed in its most severe form in 20% of patients using POCUS-IVC (point-of-care ultrasound of the inferior vena cava). In this pilot study, we detected substantial volume shifts during passive leg raise and after albumin infusion using both POCUS-IVC and a novel external jugular vein compression technique (CPMX2) in parallel. CPMX2 appeared more sensitive to dynamic changes during passive leg raise and identified a larger proportion of patients with intravascular volume overload following intravenous albumin. These findings suggest that CPMX2 could serve as a promising non-invasive tool for early assessment and individualized monitoring of volume status in decompensated cirrhosis.